Literature DB >> 1974480

Two different types of dynorphin-A-immunoreactive terminals in rat substantia nigra.

R Riesenberg1, C Nitsch.   

Abstract

The opioid peptide dynorphin A (1-17) is the third transmitter identified in the striatonigral projection, the other two being gamma-aminobutyric acid (GABA) and substance P. The ultrastructural features of the dynorphinergic terminals in substantia nigra/pars reticulata were studied using pre-embedding immunocytochemistry with the classical peroxidase-antiperoxidase-diaminobenzidine-method; these features were compared with GABAergic boutons visualized with an immunogold method. Two distinct types of dynorphin-A-immunoreactive boutons could be identified: (1) type A (81%) possessing characteristics similar to the GABAergic nerve endings in this region, i.e., large pleomorphic vesicles and symmetric synaptic contacts; (2) type B (19%) displaying asymmetric synaptic zones and small, mostly round vesicles. These results are in agreement with physiological studies suggesting a dual action of dynorphin A in substantia nigra.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1974480     DOI: 10.1007/bf00329443

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  39 in total

1.  Antisera to gamma-aminobutyric acid. II. Immunocytochemical application to the central nervous system.

Authors:  P Somogyi; A J Hodgson; I W Chubb; B Penke; A Erdei
Journal:  J Histochem Cytochem       Date:  1985-03       Impact factor: 2.479

2.  Chronic haloperidol and clozapine differentially affect dynorphin peptides and substance P in basal ganglia of the rat.

Authors:  I Nylander; L Terenius
Journal:  Brain Res       Date:  1986-08-13       Impact factor: 3.252

3.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

4.  Application of avidin-ferritin and peroxidase as contrasting electron-dense markers for simultaneous electron microscopic immunocytochemical labelling of glutamic acid decarboxylase and tyrosine hydroxylase in the rat arcuate nucleus.

Authors:  C Leranth; H Sakamoto; N J MacLusky; M Shanabrough; F Naftolin
Journal:  Histochemistry       Date:  1985

5.  Steady state levels of pro-dynorphin-related end products in the striatum and substantia nigra of the adult rhesus monkey.

Authors:  R M Dores; H Akil
Journal:  Peptides       Date:  1985       Impact factor: 3.750

6.  Synaptic connections of substance P-immunoreactive nerve terminals in the substantia nigra of the rat. A correlated light- and electron-microscopic study.

Authors:  P Somogyi; J V Priestley; A C Cuello; A D Smith; J P Bolam
Journal:  Cell Tissue Res       Date:  1982       Impact factor: 5.249

7.  A model of chronic pain in the rat: high-resolution neuroanatomical approach identifies alterations in multiple opioid systems in the periaqueductal grey.

Authors:  M J Millan; B J Morris; F C Colpaert; A Herz
Journal:  Brain Res       Date:  1987-07-28       Impact factor: 3.252

8.  Dynorphin peptides in human substantia nigra.

Authors:  I Christensson-Nylander; L Terenius
Journal:  Neuropeptides       Date:  1985-09       Impact factor: 3.286

9.  Electrophysiological evidence for a non-opioid interaction between dynorphin and GABA in the substantia nigra of the rat.

Authors:  B C Robertson; D W Hommer; L R Skirboll
Journal:  Neuroscience       Date:  1987-11       Impact factor: 3.590

10.  Immunocytochemical localization of enkephalin in the neostriatum of rat brain: a light and electron microscopic study.

Authors:  V M Pickel; K K Sumal; S C Beckley; R J Miller; D J Reis
Journal:  J Comp Neurol       Date:  1980-02-15       Impact factor: 3.215

View more
  1 in total

1.  Synaptic localization of kappa opioid receptors in guinea pig neostriatum.

Authors:  C Jomary; J E Gairin; A Beaudet
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-15       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.